Communicable & Infectious Disease News
Infectious Disease Articles
CDC Expands Booster Shot Eligibility and Strengthens Recommendations for 12-17 Year Olds
Today, CDC is endorsing the Advisory Committee on Immunization Practices’ (ACIP) recommendation to expand eligibility of booster doses to those 12 to 15 years old. CDC now recommends that adolescents age 12 to 17 years old should receive a booster shot 5 months after their initial Pfizer-BioNTech vaccination series.
CDC Recommends Pfizer Booster at 5 Months, Additional Primary Dose for Certain Immunocompromised Children
CDC is updating our recommendation for when many people can receive a booster shot, shortening the interval from 6 months to 5 months for people who received the Pfizer-BioNTech COVID-19 Vaccine.
Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19
Given what we currently know about COVID-19 and the Omicron variant, CDC is shortening the recommended time for isolation for the public.
Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults
The FDA issued an emergency use authorization for Merck’s molnupiravir for the treatment of mild-to-moderate COVID-19 in certain adults.
First COVID-19 Omicron Variant Case Detected in South Dakota
First COVID-19 OmicronVariant Case Detected in South Dakota
CDC Updates and Shortens Recommended Isolation and Quarantine Period for General Population
Today, the FDA issued an emergency use authorization for the first oral antiviral for treatment of COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds).